Post-transcriptional regulation of gene expression by degradation of messenger RNAs

Recent evidence suggests that gene expression may be regulated, at least in part, at post‐transcriptional level by factors inducing the extremely rapid degradation of messenger RNAs. These factors include reactions between adenyl‐uridyl‐rich elements (AREs) of the relevant mRNA and either specific p...

Full description

Saved in:
Bibliographic Details
Published inJournal of cellular physiology Vol. 195; no. 3; pp. 356 - 372
Main Authors Bevilacqua, Annamaria, Ceriani, Maria Cristina, Capaccioli, Sergio, Nicolin, Angelo
Format Journal Article
LanguageEnglish
Published New York Wiley Subscription Services, Inc., A Wiley Company 01.06.2003
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Recent evidence suggests that gene expression may be regulated, at least in part, at post‐transcriptional level by factors inducing the extremely rapid degradation of messenger RNAs. These factors include reactions between adenyl‐uridyl‐rich elements (AREs) of the relevant mRNA and either specific proteins that bind to these elements or exosomes. This review deals with examples of the proteins (AU‐rich binding proteins, AUBPs) and exosomes, which have been shown to form complexes with AREs and bring about rapid degradation of the relevant mRNA, and with certain other factors, which protect the RNA from such degradation. The biochemical and physiological factors underlying the stability of messenger RNAs carrying the ARE motifs will be reviewed in the light of their emerging significance for cell physiology, human pathology, and molecular medicine. We also consider the possible application of the results of recent insights into the mechanisms to pharmacological interventions to prevent or cure disorders, especially developmental disorders, which the suppression of gene expression may bring about. Molecular targeting of specific steps in protein degradation by synthetic compounds has already been utilized for the development of pharmacological therapies. © 2003 Wiley‐Liss, Inc.
Bibliography:Associazione Italiana per la Ricerca sul Cancro
Consiglio Nazionale delle Ricerche
Ministero Istruzione, Universitá e Ricerca
istex:5E8026F20F78F4967682F1038679820A98DAE068
ark:/67375/WNG-053GW9K9-3
ArticleID:JCP10272
Ministero Sanità
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0021-9541
1097-4652
DOI:10.1002/jcp.10272